Form 4: Prime Medicine Executive Transfers Shares to Family Trust for Estate Planning
SEC Form 4
Keith Michael Gottesdiener, a director and officer at Prime Medicine, reported the transfer of shares to a family trust for estate planning purposes.
Summary
- On October 8, 2024, Keith Michael Gottesdiener, President and CEO of Prime Medicine, transferred 226,925 shares of Prime Medicine common stock to a family trust.
- The transfer was made by Gottesdiener's spouse for bona fide estate planning purposes and involved no consideration.
- Following the transaction, Gottesdiener indirectly owns 50,241 shares through his spouse and 682,259 shares through a trust.
- He also indirectly owns 1,317,741 shares through another trust where his spouse is a co-trustee.
- Gottesdiener disclaims beneficial ownership of the shares held in the trusts except to the extent of any pecuniary interest therein.
Sentiment
Score: 5
Explanation: The document reports a routine transaction with neutral implications.
Positives
- The transaction appears to be a standard estate planning measure.
Industry Context
Share transfers for estate planning are common among executives and directors of publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 10/08/2024 | Date of share transfer to family trust |
| 10/10/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.